(Q46451633)

English

Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease

scientific article published in June 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

1 reference

based on heuristic

inferred from title

author name string

P-T T Pham

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

A H Wilkinson

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

H A Gritsch

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

P C T Pham

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

J M Miller

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

C R Lassman

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

G M Danovitch

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

34

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

1178-1181

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid o

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-alpha-induced acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and treatment of transplant-related lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful outcome with a "quintuple approach" of posttransplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2902754-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0041-1345(02)02754-9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/12072308

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46451633&oldid=2112396284"